Per Wold-Olsen was born on 6 November 1947 and is a Norwegian national. He holds an MBA in Economics Administration as well as an MBA in Management and Marketing. Per joined Merck & Co. (MSD) in 1974. He became Managing Director of the Norwegian subsidiary in 1976 and Regional Director and Vice President of the Scandinavian region in 1986. In 1991, Per Wold-Olsen was appointed Senior Vice President for Worldwide Human Health Marketing of Merck & Co. Inc. in the US, and in 1994, he was appointed President of Human Health Europe of Merck & Co., Inc. In 1997, his region increased to include Eastern Europe, the Middle East and Africa, as well as Worldwide Human Health Marketing.
In 2005, he was appointed President of the Human Health Intercontinental Region, Merck & Co. Inc. From 1994 to 2006, he was also a member of Merck’s Management Committee. Per Wold-Olsen is Chairman of the Board of Directors of GN Store Nord A/S, Denmark and Medicines for Malaria Venture, Switzerland, and serves on the Board of Directors of Gilead Sciences Inc., United States of America. He is also a board member of Novo Holdings since 2011.
Jacques Attali was born on the 1st of November 1943.
Graduate from the Ecole Polytechnique and the Ecole Nationale d’Administration, he was the Special Adviser to French President François Mitterrand during 10 years. He founded 4 International Institutions : Action contre la faim, EUREKA, BERD and Positive Planet.
The Positive Planet
NGO (and the other entities of the Positive Planet Institution) has been promoting the Positive Economy and supporting the creation of positive businesses for the last 22 years, in the deprived neighbourhoods of France, Africa and the Middle East. Positive Planet has supported more than 11 million micro-entrepreneurs.
Jacques Attali has written more than 1000 op-eds in the french magazine L’Express as well as more than 80 books sold in 9 million copies and translated in to 22 languages.
He is now columnist for the French magazine, les Echos.
He has conducted several orchestras over the world (Paris, Grenoble, London, Jerusalem, Shanghai, Astana, Montreal, Lausanne, Bruxelles, Helsinki, etc.).
Jeffrey L. Sturchio
Jeffrey L. Sturchio is President and CEO at Rabin Martin, a global health strategy consulting firm, and former President and CEO of the Global Health Council. Before joining the Council in 2009, Dr. Sturchio was vice president of Corporate Responsibility at Merck & Co. Inc., president of The Merck Company Foundation and chairman of the US Corporate Council on Africa (CCA). While at Merck & Co., Inc., for more than a decade he was a leader of the company’s global HIV/AIDS policy and was centrally involved in the UN/Industry Accelerating Access Initiative established in 2000 to help improve HIV/AIDS care and treatment in the developing world. He was a member of the board of the African Comprehensive HIV/AIDS Partnerships in Botswana (2005-2009) and a member of the private sector delegation to the Board of the Global Fund to Fight AIDS, TB and Malaria (2002-2008). He is chairman of the Corporate Council on Africa, chairman of the BroadReach Institute for Training and Education and a member of the boards of ACHAP, the Chemical Heritage Foundation and Friends of the Global Fight Against AIDS, TB and Malaria. Dr. Sturchio is also currently a visiting scholar at the Institute for Applied Economics, Global Health and the Study of Business Enterprise at The Johns Hopkins University; Senior Associate at the Center for Strategic and International Studies; a principal of the Modernizing Foreign Assistance Network; Fellow of the American Association for the Advancement of Science; a member of the Council on Foreign Relations and the Arthur W. Page Society; and an advisor to amfAR, the Clinton Global Initiative, Intrahealth International and the NCD Alliance. He received an AB in history from Princeton University and a PhD in the history and sociology of science from the University of Pennsylvania. His publications include Noncommunicable diseases in the developing world: addressing global gaps in policy and research (edited with L. Galambos, Johns Hopkins University Press, 2013).